ADVERTISEMENT
RHEUMATOLOGY
More Diverse Clinical Trials Can Lead to Improved Outcomes in Lupus
12/10/2018
Dr Saira Sheikh from University of North Carolina at Chapel Hill discusses the lack of diversity in Lupus clinical trials, the new ACR partnership aimed at increasing access to trials, the overall impact on the rheumatologist's ability to manage patients, and more.
Saira Sheikh, MD, is a rheumatologist and allergist immunologist, and director of the Lupus and Clinical Trials Programs at UNC Thurston Arthritis Research Center at the University of North Carolina at Chapel Hill in North Carolina.